Friday, February 1, 2019

Method to 'turn off' mutated melanoma

Melanoma is the deadliest form of skin cancer and notorious for its resistance to conventional chemotherapy. Approximately 25 percent of melanoma is driven by oncogenic mutations in the NRAS gene, making it a very attractive therapeutic target. However, despite decades of research, no effective therapies targeting NRAS have been forthcoming.

from Top Health News -- ScienceDaily http://bit.ly/2G1ai0g

No comments:

Post a Comment

A simple blood test mismatch linked to kidney failure and death

A major global study suggests that a hidden mismatch between two common blood tests could quietly signal serious trouble ahead. When results...